Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MET-097 by Metsera for Obesity: Likelihood of Approval
MET-097 is under clinical development by Metsera and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...